- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04679090
Physical Activity Levels and Functional Improvement in Breast Cancer Survivors (CanEX)
February 17, 2021 updated by: University of New Brunswick
Do Physical Activity Levels Predict Functional Improvements Following a Structured Exercise Program for Women Living With Breast Cancer?
The main objective of our project is to describe what characteristics (e.g., age, current physical activity level) women present when starting the exercise program are potentially associated with an improvement in functional abilities measured with different tests such as the distance you can cover while walking for six minutes.
Study Overview
Detailed Description
The main research objective is to investigate the relationship between baseline physical activity and improvement in physical function, quantified using changes in 6-minute walk test (6MWT) results over the course of the 12-week program.
An association is hypothesized to exist between the two variables even when adjusted for weeks into treatment.
The goal of the 6MWT is to cover as much distance as possible in six minutes, using as many breaks s necessary.
The test is often performed using a 20-meter hallway but requires no specific equipment.
A recent study reported that the result of the 6MWT could be used as a measure of the major components of global health in women with breast cancer, making its use in our research especially relevant.
Aside from physical functions, baseline characteristics will also be used to determine what characteristics, if any, are associated with health and psychosocial outcomes such as quality of life, social connectedness/support, and mental well-being.
The data collected is certain to fill a gap in the literature, and will therefore be likely published in an important journal in the field.
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Brunswick
-
Fredericton, New Brunswick, Canada
- Recruiting
- University of New Brunswick
-
Contact:
- Danielle Bouchard
- Phone Number: 5064433908
- Email: dboucha1@unb.ca
-
-
Newfoundland and Labrador
-
St. John's, Newfoundland and Labrador, Canada
- Recruiting
- Memorial University of Newfoundland
-
Contact:
- Erin McGowan
- Phone Number: 7098647269
- Email: emcgowan@mun.ca
-
-
Prince Edward Island
-
Charlottetown, Prince Edward Island, Canada
- Recruiting
- University of Prince Edward Island
-
Contact:
- Travis Saunders
- Phone Number: 9025660641
- Email: trsaunders@upei.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Have received a diagnosis of breast cancer in your lifetime
- 19 years of age and older
- Cleared by medical team to participate in the study
- Have the intention to exercise at the facility for the duration of the study
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Participant
Participants will answer a series of questionnaires, wear a physical activity tracker (pedometer) and do functional tests (six minute walk test, chair stand test, balance, back scratch, sit and reach, leg strength and hand strength) pre and post.
|
Participants will exercise twice a week for twelve weeks total.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Walking speed
Time Frame: Pre and post (after 12 weeks)
|
6-minute walk test (meters walked)
|
Pre and post (after 12 weeks)
|
|
Balance
Time Frame: Pre and post (after 12 weeks)
|
One leg stand test (seconds)
|
Pre and post (after 12 weeks)
|
|
Strength, Hand grip
Time Frame: Pre and post (after 12 weeks)
|
Amount of force that can be exerted during grip squeeze (kg)
|
Pre and post (after 12 weeks)
|
|
Strength, Chair stand test
Time Frame: Pre and post (after 12 weeks)
|
Chair stand test, number of chair stand in 30 seconds
|
Pre and post (after 12 weeks)
|
|
Flexibility, back scratch test
Time Frame: Pre and post (after 12 weeks)
|
Back scratch test (cm)
|
Pre and post (after 12 weeks)
|
|
Flexibility, sit and reach
Time Frame: Pre and post (after 12 weeks)
|
Sit and reach test
|
Pre and post (after 12 weeks)
|
|
Physical Activity Level
Time Frame: Pre and post (after 12 weeks)
|
Pedometer to determine minutes in moderate-vigorous physical activity and steps per day
|
Pre and post (after 12 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attendance
Time Frame: Pre and post (after 12 weeks)
|
Amount of exercise sessions attended during the 12-week program
|
Pre and post (after 12 weeks)
|
|
Weight
Time Frame: Pre and post (after 12 weeks)
|
Weight of individual (kg)
|
Pre and post (after 12 weeks)
|
|
Height
Time Frame: Pre and post (after 12 weeks)
|
Height of individual (cm)
|
Pre and post (after 12 weeks)
|
|
Resting Blood Pressure
Time Frame: Pre and post (after 12 weeks)
|
Systolic and diastolic blood pressure (mmHg)
|
Pre and post (after 12 weeks)
|
|
Resting Heart Rate
Time Frame: Pre and post (after 12 weeks)
|
Resting heart rate (beats per minute)
|
Pre and post (after 12 weeks)
|
|
Body-mass Index
Time Frame: Pre and post (after 12 weeks)
|
Measure of body fat based on height and weight (kg/m^2)
|
Pre and post (after 12 weeks)
|
|
Waist Circumference
Time Frame: Pre and post (after 12 weeks)
|
Measurement around the waist (cm)
|
Pre and post (after 12 weeks)
|
|
FANTASTIC Lifestyle Checklist
Time Frame: Pre and post (after 12 weeks)
|
Meaningful improvement above day-to-day variability on the 6MWT
|
Pre and post (after 12 weeks)
|
|
Functional Assessment of Cancer Therapy General (FACT - G)
Time Frame: Pre and post (after 12 weeks)
|
27-item questionnaire designed to measure four domains of HRQOL in cancer patients: Physical, social, emotional, and functional well-being
|
Pre and post (after 12 weeks)
|
|
Functional Assessment of Cancer Therapy Fatigue (FACT - F)
Time Frame: Pre and post (after 12 weeks)
|
40-item measure that assesses self-reported fatigue and its impact upon daily activities and function
|
Pre and post (after 12 weeks)
|
|
Depression Anxiety Stress Scales (DASS)
Time Frame: Pre and post (after 12 weeks)
|
42-item self report instrument designed to measure the three related negative emotional states of depression, anxiety and tension/stress.
|
Pre and post (after 12 weeks)
|
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Pre and post (after 12 weeks)
|
A self-report questionnaire that assesses sleep quality over a 1-month time interval
|
Pre and post (after 12 weeks)
|
|
Godin-Shephard Leisure-Time Physical Activity Questionnaire
Time Frame: Pre and post (after 12 weeks)
|
Questionnaire used to identify self-reported leisure-time physical activity
|
Pre and post (after 12 weeks)
|
|
Age
Time Frame: Pre and post (after 12 weeks)
|
Age (years)
|
Pre and post (after 12 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Danielle Bouchard, University of New Brunswick
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 11, 2018
Primary Completion (ANTICIPATED)
April 1, 2021
Study Completion (ANTICIPATED)
April 1, 2021
Study Registration Dates
First Submitted
December 1, 2020
First Submitted That Met QC Criteria
December 17, 2020
First Posted (ACTUAL)
December 22, 2020
Study Record Updates
Last Update Posted (ACTUAL)
February 18, 2021
Last Update Submitted That Met QC Criteria
February 17, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- University Brunswick
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
Clinical Trials on Exercise Program
-
Azienda Sanitaria Locale CN1 CuneoRecruiting
-
Kafrelsheikh UniversityRecruitingLow Back Pain | Pilates Exercises | Nonspecific | Postnatal WomenEgypt
-
Hull University Teaching Hospitals NHS TrustTerminated
-
University of Vic - Central University of CataloniaCol·legi Fisioterapeutes de CatalunyaNot yet recruitingBreast Cancer | Physical Activity | Colorectal Cancer | Strength and Endurance | Lung Cancer (Non-Small Cell) | Neoadjuvant Chemotherapy ToleranceSpain
-
Marmara UniversityRecruitingTendinopathy | Shoulder PainTurkey
-
Munzur UniversityRecruiting
-
Akdeniz UniversityCompletedAnkylosing SpondylitisTurkey
-
University of AlexandriaCompleted
-
Chang Gung Memorial HospitalCompleted
-
Rosimeire Simprini PadulaUnknownMusculoskeletal Disorder of the NeckBrazil